The Effect of the Use of Sterile Transparent Film Dressing in Newborns
Launched by YUKSEK IHTISAS HOSPITAL · Jan 20, 2023
Trial Information
Current as of June 02, 2025
Completed
Keywords
ClinConnect Summary
It has been reported that effective catheter fixation will reduce the risk of catheter unavailability for specific reasons and the incidence of catheter-related complications. Intravenous cannulas are usually fixed with a thin board, a bandage, and tape. There is no standard way of using PIVC dressings in Turkey. After the catheter is inserted into the vein, gauze and a blaster, sterile transparent dressing materials, or just a blaster, are used to prevent contact of the fixed part and the area of intervention with the external environment. Transparent dressing used for catheter fixation co...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • less than 4 kg (due to the infiltration scale criteria)
- • PICV was inserted for the first time
- Exclusion Criteria:
- • existing catheter,
- • who has a catheter other than PICV (PICC, umbilical catheter, etc.),
- • sterile transparent film dressing, tape, babies with allergies to antiseptic solution and catheter,
- • with immunodeficiency, and with skin problems that prevent catheter opening
About Yuksek Ihtisas Hospital
Yüksek İhtisas Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a multidisciplinary approach, the hospital collaborates with researchers and healthcare professionals to conduct rigorous studies across various therapeutic areas. Yüksek İhtisas Hospital's state-of-the-art facilities and experienced staff ensure high standards of safety and ethical practice, making it a trusted partner in the clinical research landscape. Through its initiatives, the hospital aims to contribute significantly to the advancement of medical knowledge and the development of new treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Suzan YILDIZ, PhD
Principal Investigator
Istanbul University - Cerrahpasa
Yağmur GÜL, BSN
Principal Investigator
Istanbul Florence Nightingale Hospital
Ozan UZUNHAN, MD
Principal Investigator
Istanbul Florence Nightingale Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials